Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Hans Hull currently holds 227,494 shares of PLIANT THERAPEUTICS, INC. (PLRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hans Hull has been a net seller of PLRX stock. They have purchased $0 and sold $3.0M worth of shares.
Hans Hull's most recent insider trade was on Jul 10, 2024, when they sold 9,900 shares at $11.56 per share.
Hans Hull serves as Executive at PLIANT THERAPEUTICS, INC. (PLRX). They have executed 31 insider transactions totaling $3.0M over their tenure at the company.
Hans Hull holds the position of Executive at PLIANT THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Hans Hull has shown a selling trading pattern, with $0 in total purchases and $3.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Hans Hull was on Apr 7, 2015, when they sold $1.0M worth of AAVL shares. This transaction involved 26,613 shares at $38.59 per share.
Hans Hull currently owns 227,494 shares of PLIANT THERAPEUTICS, INC. (PLRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Hans Hull's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Hans Hull has 31 Form 4 filings on record as an insider at PLIANT THERAPEUTICS, INC..
Set alerts for Hans Hull and 40,000+ other insiders.